Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Tumor-suppressive effects of atelocollagen-conjugated hsa-miR-520d-5p on un-differentiated cancer cells in a mouse xenograft model

Fig. 1

Schematic of the study design and processes. Atelocollagen and miR-520d-5p were conjugated following the manufacturer’s instructions, and the resulting complex was injected into immunodeficient mice that were inoculated with cancer cells. In addition, 520d-conjugated atelocollagen was administered to mice via three different methods (see Methods for further details)

Back to article page